Sun Pharmaceuticals Industries Ltd SUNPHARMA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
At ESMO 2026, Sun Pharma to Present Long-Term Follow-up Data on UNLOXCYT® (cosibelimab-ipdl) from One of the Largest Prospective Studies in Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
-
Sun Pharma Announces UNLOXCYT® (cosibelimab-ipdl) Has Received a Category 2A Preferred Designation in the Updated NCCN Guidelines for Locally Advanced Cutaneous Squamous Cell Carcinoma (laCSCC) Patients Who Are Not Candidates for Curative Surgery or Curative Radiation
-
Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
-
New LEQSELVI® (deuruxolitinib) Two-Year Data in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026
-
First-Ever Standardized U.S. Treatment Recommendations Issued for Adults with Severe Alopecia Areata; Sun Pharma Welcomes Milestone
-
Sun Pharma and Christian Siriano Launch "Regrowth Restyled" to Inspire Adults Living with Severe Alopecia Areata
-
India's Sun Pharma to Buy U.S. Healthcare Company Organon in $11.75 Billion Deal — 2nd Update
-
India's Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal - Update
Trading Information
- Previous Close Price
- ₹1,757.50
- Day Range
- ₹1,752.70–1,771.50
- 52-Week Range
- ₹1,583.70–2,046.90
- Bid/Ask
- ₹1,761.00 / ₹1,708.00
- Shares Outstanding
- 2.40B
- Market Cap
- ₹4.23T
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 36.51
- Price/Sales
- 7.07
- Dividend Yield (Trailing)
- 0.91%
- Dividend Yield (Forward)
- 0.91%
- Dividend Payment Schedule
- Feb, Aug
- Total Yield
- 0.91%
Company Profile
Sun Pharmaceuticals Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical ingredients(APIs). The Company has various manufacturing locations spread across the country with trading and other incidental and related activities extending to the world-wide market. The company's reportable segments are India, United States of America, Emerging markets, and Rest of the world. The company generates majority of revenue from India. Its products are Speciality Medications, Generic Medications, Over-the-Counter Medications, Active Pharmaceutical Ingredients, and Anti Retro Viral Medications.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 28,925
- Website
- https://www.sunpharma.com
Valuation
|
Metric
|
SUNPHARMA
|
|---|---|
Price/Earnings (Normalized) | 36.51 |
Price/Book Value | 5.05 |
Price/Sales | 7.07 |
Price/Cash Flow | 31.57 |
Price/Earnings
SUNPHARMA
Financial Strength
|
Metric
|
SUNPHARMA
|
|---|---|
Quick Ratio | 2.18 |
Current Ratio | 2.82 |
Interest Coverage | 45.11 |
Quick Ratio
SUNPHARMA
Profitability
|
Metric
|
SUNPHARMA
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SUNPHARMA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|>bGXHr% | LOCK|%YJ> | $71B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|$>?fK@r> | LOCK|c<dRK | $49B | |||
| Haleon PLC ADR
HLN
| LOCK|Z$#wm^ | LOCK|r#s | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|Gpqj$^P | LOCK|^YN | $32B | |||
| Viatris Inc
VTRS
| LOCK|!Hm<<Lq | LOCK|$#f | $22B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|%Y>Nfg | LOCK|hc | $12B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|$?> | LOCK|?Q& | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|?d&<&L% | LOCK|fW% | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|%$b!dc | LOCK|$hN!J | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|qscFmh | LOCK|M!% | $2B |
United States